Mesa Laboratories: Hard To Set The Right Diagnosis
Source: SeekingAlpha
2026-03-10 17:54:42 ET
In the fall, I believed that appealing territory had been reached in the case of shares of life science tools provider Mesa Laboratories, Inc. ( MLAB ). Shares recovered from lows in the $70s to nearly the $100 mark in recent weeks, with shares retesting the lows following an unexpected CEO transition....
Read the full article on Seeking Alpha
For further details see:
Mesa Laboratories: Hard To Set The Right Diagnosis
Mesa Laboratories Inc.
NASDAQ: MLAB
MLAB Trading
-2.21% G/L:
$78.04 Last:
72,074 Volume:
$78.26 Open:
MLAB Latest News
March 09, 2026 04:30:00 pm
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
February 18, 2026 09:00:00 am
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
MLAB Stock Data
$511,514,812
5,254,097
1.16%
49
N/A
Biotechnology & Life Sciences
Healthcare
US
Lakewood
